secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001295947-24-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Q3 revenue $282.7M (+2.6% YoY), raises FY EPS outlook to ~$4.33
--------------------------------------------------------------------------------

- Diluted EPS $1.06 in Q3, up 2.2% vs $1.04 prior year; net income $53.0M.
- North America OTC revenue $236.6M flat; International OTC rose to $46.2M (+19.7%) driven by Hydralyte.
- Net debt ~$1.1B; leverage ratio improved to 2.9x; free cash flow $69.5M in Q3.
- Full-year revenue guidance reaffirmed $1,135-1,140M; diluted EPS raised from $4.27-4.32 to ~$4.33.
- Completed $25M share repurchase in Q1; no new buyback authorization announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000006/0001295947-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000006/pbh-20240208.htm
  HTML page:      https://secwatch.observer/filing/0001295947-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer